Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First preclinical results presented for a novel HER2-targeted ADC

May 4, 2015

Anti-GDF-15 MAb restores CACS-associated phenotypic and metabolic changes

May 4, 2015

Anti-inflammatory effects of amylin(28-33) described for the first time

April 30, 2015

Promising first-in-human phase I safety and biodistribution results for 124I-PEG-AVP-0458

April 30, 2015

RG-7800: safety and tolerability in humans

April 30, 2015

MediciNova reports interim results from study of ibudilast for ALS

April 30, 2015

Phase I trial confirms anti-HCV activity of SB-9200

April 30, 2015

Preclinical and phase I clinical results for PXS-4728A

April 30, 2015

Potent in vitro activity of AP-138, a second-generation plectasin derivative

April 30, 2015

Clinical development of the nucleoside NS5B inhibitor MIV-802 for HCV infection

April 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...